152 related articles for article (PubMed ID: 12416229)
1. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
Demchenko EA; Berezina AV; Panov AV
Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
[No Abstract] [Full Text] [Related]
2. [ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque].
Zaslavskaia RM; Shcherban' EA; Logvinenko SI
Klin Med (Mosk); 2005; 83(10):19-21. PubMed ID: 16320839
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
4. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
6. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
7. [Administration of various dosages of retard isosorbide-5-mononitrate in patients with stable angina pectoris on combined therapy].
Chernova EV; Kuchinskaia NG; Barysheva OV; Bezborodova IuV; Shatukhina EIu; Aleshin OI
Klin Med (Mosk); 2002; 80(1):55-7. PubMed ID: 11855323
[TBL] [Abstract][Full Text] [Related]
8. [Antianginal effectiveness of regular isosorbide-5-mononitrate (monochinkwe retard) intake].
Golikov AP; Allenova IB; El'kina NS
Ter Arkh; 1999; 71(12):52-3. PubMed ID: 10647204
[No Abstract] [Full Text] [Related]
9. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Demin AA; Aksenova EA
Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
[TBL] [Abstract][Full Text] [Related]
10. [Nitrates in therapy of effort angina in hypotensive patients].
Idrisova EM; Borovkova NV; Kladieva EA; Chernov VI; Demochko AV; Shishkina AA; Vorob'eva EV; Karpov RS
Klin Med (Mosk); 2003; 81(11):54-8. PubMed ID: 14689713
[TBL] [Abstract][Full Text] [Related]
11. [Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort].
Belenkov IuN; Ageev FT; Nuraliev EIu; Prostakova TS; Dzhakhangirov TSh
Kardiologiia; 2005; 45(9):11-5. PubMed ID: 16234785
[No Abstract] [Full Text] [Related]
12. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
13. [How is antianginal therapy with pentaerythritol tetranitrate executed?].
Schneider CA
Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490
[No Abstract] [Full Text] [Related]
14. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
15. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
16. [Nitrates. The place in contemporary therapy of ischemic heart disease].
Martsevich SIu
Kardiologiia; 2005; 45(7):69-72. PubMed ID: 16091666
[No Abstract] [Full Text] [Related]
17. [The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
Belousov IuB; Egorova NA; Karasev AV; Upnitskiĭ AA
Ter Arkh; 1997; 69(9):45-7. PubMed ID: 9411825
[TBL] [Abstract][Full Text] [Related]
18. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
Arthur RM; Mehmel H
Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
[TBL] [Abstract][Full Text] [Related]
19. [A new antianginal preparation: isosorbide-5-mononitrate].
Martsevich SIu; Metelitsa VI; Slastnikova ID; Simkhaev LS; Egorov LV; Blagodatskikh SV
Kardiologiia; 1990 Oct; 30(10):44-6. PubMed ID: 2290270
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis.
Jansen R; Niemeyer MG; Cleophas TJ; Zwinderman AH
Angiology; 2000 Dec; 51(12):1007-12. PubMed ID: 11132992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
